American College of Medical Genetics and Genomics (ACMG)

acmg.net

The American College of Medical Genetics and Genomics (ACMG) provides education, resources and a voice for the medical genetics and genomics profession. To make genetic services available to and improve the health of the public, the ACMG promotes the development and implementation of methods to diagnose, treat and prevent genetic diseases.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Research

PRELLIS BIOLOGICS ANNOUNCES COLLABORATION AND LICENSE AGREEMENT WITH BRISTOL MYERS SQUIBB

Prellis Biologics, Inc. | January 14, 2022

news image

Prellis Biologics, Inc. (Prellis), a Bay Area biotechnology company, announced that it has entered into a multi-target drug discovery collaboration and licensing agreement with Bristol Myers Squibb utilizing Prellis Biologics’ first-in-class externalized human immune system based on human lymph node organoids. The collaboration leverages Prellis’ EXIS platform that can break tolerance mechanisms in vitro to create high affinity human antibodies targeting human proteins. ...

Read More

MedTech, AI

FOXO TECHNOLOGIES™ COLLABORATES WITH DATAROBOT TO PAVE THE WAY FOR AI-DRIVEN EPIGENETIC BIOMARKER RESEARCH IN HUMAN LONGEVITY

Businesswire | August 18, 2023

news image

FOXO Technologies Inc. a leader in the field of commercializing epigenetic biomarker technology, has advanced in its mission to utilize the power of epigenetics and artificial intelligence to generate data-driven insights that promote optimal health and longevity. In collaboration with DataRobot, the leader in Value-Driven AI, FOXO has successfully harnessed the powers of predictive AI and high-throughput automation to estimate factors associated with human longevity using epigenetic bioma...

Read More

MedTech

BIOAGE PARTNERS WITH AGE LABS TO DECIPHER HEALTHY LONGEVITY USING SAMPLES AND DATA FROM A PREEMINENT NORTHERN EUROPEAN BIOBANK

BioAge Labs, Inc. | August 24, 2022

news image

BioAge Labs, Inc. a biotechnology company developing therapeutics that target the molecular causes of aging to extend healthy human lifespan, today announced that it has initiated a partnership agreement with Age Labs AS a diagnostic company that develops tests for the early detection of age-related diseases. Under the terms of the agreement, BioAge will perform multi-omics analyses on samples and health records from the Nord-Trøndelag Health Study biobank collected from more than 100,000...

Read More

Industry Outlook

OPENTRONS PARTNERS WITH ZYMO RESEARCH TO AUTOMATE KEY MICROBIOME CHEMISTRIES ON THE OPENTRONS FLEX™

PRNewswire | June 16, 2023

news image

Opentrons Labworks, Inc., a leader in lab automation and makers of accessible lab robotics and Zymo Research Corp, a life science reagent company, are collaborating to transform microbiome and metagenome analysis by fully automating comprehensive, end-to-end workflows from sample collection through library preparation on the Opentrons Flex. Traditional methods of microbiome analysis have provided valuable insights across various applications; however, this approach frequently fa...

Read More
news image

Research

PRELLIS BIOLOGICS ANNOUNCES COLLABORATION AND LICENSE AGREEMENT WITH BRISTOL MYERS SQUIBB

Prellis Biologics, Inc. | January 14, 2022

Prellis Biologics, Inc. (Prellis), a Bay Area biotechnology company, announced that it has entered into a multi-target drug discovery collaboration and licensing agreement with Bristol Myers Squibb utilizing Prellis Biologics’ first-in-class externalized human immune system based on human lymph node organoids. The collaboration leverages Prellis’ EXIS platform that can break tolerance mechanisms in vitro to create high affinity human antibodies targeting human proteins. ...

Read More
news image

MedTech, AI

FOXO TECHNOLOGIES™ COLLABORATES WITH DATAROBOT TO PAVE THE WAY FOR AI-DRIVEN EPIGENETIC BIOMARKER RESEARCH IN HUMAN LONGEVITY

Businesswire | August 18, 2023

FOXO Technologies Inc. a leader in the field of commercializing epigenetic biomarker technology, has advanced in its mission to utilize the power of epigenetics and artificial intelligence to generate data-driven insights that promote optimal health and longevity. In collaboration with DataRobot, the leader in Value-Driven AI, FOXO has successfully harnessed the powers of predictive AI and high-throughput automation to estimate factors associated with human longevity using epigenetic bioma...

Read More
news image

MedTech

BIOAGE PARTNERS WITH AGE LABS TO DECIPHER HEALTHY LONGEVITY USING SAMPLES AND DATA FROM A PREEMINENT NORTHERN EUROPEAN BIOBANK

BioAge Labs, Inc. | August 24, 2022

BioAge Labs, Inc. a biotechnology company developing therapeutics that target the molecular causes of aging to extend healthy human lifespan, today announced that it has initiated a partnership agreement with Age Labs AS a diagnostic company that develops tests for the early detection of age-related diseases. Under the terms of the agreement, BioAge will perform multi-omics analyses on samples and health records from the Nord-Trøndelag Health Study biobank collected from more than 100,000...

Read More
news image

Industry Outlook

OPENTRONS PARTNERS WITH ZYMO RESEARCH TO AUTOMATE KEY MICROBIOME CHEMISTRIES ON THE OPENTRONS FLEX™

PRNewswire | June 16, 2023

Opentrons Labworks, Inc., a leader in lab automation and makers of accessible lab robotics and Zymo Research Corp, a life science reagent company, are collaborating to transform microbiome and metagenome analysis by fully automating comprehensive, end-to-end workflows from sample collection through library preparation on the Opentrons Flex. Traditional methods of microbiome analysis have provided valuable insights across various applications; however, this approach frequently fa...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us